To Assess Safety, Tolerability and PK of NEX-20A, a Subcutaneous Prolonged-release Injection to Healthy Subjects
Clinical trial NCT05643248 · COMPLETED
Trial details
- NCT number
- NCT05643248
- Sponsor
- Nanexa AB
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-28
- Primary completion
- 2023-09-26
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.